Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ditazol

Known as: 2,2'-(4,5-Diphenyloxazol-2-ylazanediyl)diethanol, Ditazole, Ethanol, 2,2'-((4,5-diphenyl-2-oxazolyl)imino)bis- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
BACKGROUND In a retrospective study, antiplatelet therapy has been shown to be associated with a decreased incidence of… Expand
1995
1995
Platelets from diabetic patients are hypersensitive to aggregating agents. An imbalance in thromboxane/prostacyclin synthesis has… Expand
1988
1988
This paper describes mass spectrometric studies on the metabolism of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-amino-oxazole (ditazole… Expand
1984
1984
The in vitro activity of the non-steroidal anti-inflammatory agent Ditazole was investigated in a group of 20 male patients at… Expand
1983
1983
A method to induce microthrombi in small mesenteric arteries (phi 15-25 microns) has been developed to study platelet reactions… Expand
1980
1980
The effects of acetylsalicylic acid (ASA) indometacin and ditazole on prostacyclin production from rabbit aortic rings were… Expand
1978
1978
Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice 
1977
1977
Ditazole (4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol) is a new drug shown to inhibit prostaglandin release from rat platelets… Expand
1977
1977
The effect of ditazole, a new antiaggregant oxazole derivative as well as its possible interaction with urokinase on the… Expand
1975
1975
The release of PGF1alpha and PGF2alpha from superfused blood platelets was studied by the combined use of two radioimmunoassay… Expand